DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2206363/pharma-stock-roundup-lly-s-new-digital-pharmacy-nvo-abbv-s-fresh-r-d-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2206363 Jan 05, 2024 - Eli Lilly (LLY) launches a new direct-to-consumer website to provide easy access to its medicines. Novo Nordisk (NVO) announces two research collaborations to develop novel treatments for cardiometabolic diseases. 0

https://www.zacks.com/stock/news/2206412/nvs-or-lly-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2206412 Jan 05, 2024 - NVS vs. LLY: Which Stock Is the Better Value Option? 0

https://www.zacks.com/commentary/2211005/these-stocks-are-showing-relative-strength-as-s-p-500-stalls-near-record-high?cid=CS-ZC-FT-investment_ideas-2211005 Jan 16, 2024 - As investors, our job isn't to predict an unknowable future. 0

https://www.zacks.com/commentary/2211986/top-analyst-reports-for-eli-lilly-linde-nextera-energy?cid=CS-ZC-FT-research_daily-2211986 Jan 18, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Linde plc (LIN) and NextEra Energy, Inc. (NEE). 0

https://www.zacks.com/commentary/2220146/top-stock-reports-for-eli-lilly-danaher-citigroup?cid=CS-ZC-FT-research_daily-2220146 Feb 02, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR) and Citigroup Inc. (C). 0

https://www.zacks.com/stock/news/2221950/compared-to-estimates-lilly-lly-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2221950 Feb 06, 2024 - While the top- and bottom-line numbers for Lilly (LLY) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. 0

https://www.zacks.com/stock/news/2222669/etfs-to-buy-as-mounjaro-powers-eli-lilly-s-q4-earnings-beat?cid=CS-ZC-FT-etf_news_and_commentary-2222669 Feb 07, 2024 - Eli Lilly and Company (LLY) posted robust fourth-quarter 2023 earnings, beating estimates on both the top and bottom lines driven by strong sales of its diabetes and weight-loss treatments. 0

https://www.zacks.com/commentary/2226833/top-stock-reports-for-mastercard-sap-crowdstrike?cid=CS-ZC-FT-research_daily-2226833 Feb 15, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), SAP SE (SAP) and CrowdStrike Holdings, Inc. (CRWD). 0

https://www.zacks.com/stock/news/2236096/nektar-nktr-q4-loss-wider-than-expected-revenue-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2236096 Mar 05, 2024 - Nektar (NKTR) reports a wider-than-expected loss in the fourth quarter of 2023 while revenue beat estimates. 0

https://www.zacks.com/stock/news/2237396/should-you-buy-red-hot-stocks-now-or-wait?cid=CS-ZC-FT-market_edge-2237396 Mar 07, 2024 - After a mesmerizing rally to start 2024, is it too late to buy the hottest stocks? 0